Livalo (Kowa Pharmaceuticals America, Inc.)
Welcome to the PulseAid listing for the Livalo drug offered from Kowa Pharmaceuticals America, Inc.. This HMG-CoA Reductase Inhibitor [EPC],Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Kowa Pharmaceuticals America, Inc. |
| NON-PROPRIETARY NAME: | pitavastatin calcium |
| SUBSTANCE NAME: | PITAVASTATIN CALCIUM |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | HMG-CoA Reductase Inhibitor [EPC],Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, FILM COATED |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2010-05-15 |
| END MARKETING DATE: | 0000-00-00 |
Livalo HUMAN PRESCRIPTION DRUG Details:
| Item Description | Livalo from Kowa Pharmaceuticals America, Inc. |
| LABELER NAME: | Kowa Pharmaceuticals America, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 1.045(mg/1) |
| START MARKETING DATE: | 2010-05-15 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 66869-104_79816fbf-5c40-4d9d-b19e-63b3398dee58 |
| PRODUCT NDC: | 66869-104 |
| APPLICATION NUMBER: | NDA022363 |
Other PITAVASTATIN CALCIUM Pharmaceutical Manufacturers / Labelers:
